1. Home
  2. GALT vs WTFCM Comparison

GALT vs WTFCM Comparison

Compare GALT & WTFCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GALT
  • WTFCM
  • Stock Information
  • Founded
  • GALT 2000
  • WTFCM N/A
  • Country
  • GALT United States
  • WTFCM United States
  • Employees
  • GALT N/A
  • WTFCM 5521
  • Industry
  • GALT Biotechnology: Pharmaceutical Preparations
  • WTFCM Major Banks
  • Sector
  • GALT Health Care
  • WTFCM Finance
  • Exchange
  • GALT Nasdaq
  • WTFCM Nasdaq
  • Market Cap
  • GALT 147.8M
  • WTFCM N/A
  • IPO Year
  • GALT N/A
  • WTFCM N/A
  • Fundamental
  • Price
  • GALT $1.04
  • WTFCM $25.30
  • Analyst Decision
  • GALT Strong Buy
  • WTFCM
  • Analyst Count
  • GALT 1
  • WTFCM 0
  • Target Price
  • GALT $11.00
  • WTFCM N/A
  • AVG Volume (30 Days)
  • GALT 1.1M
  • WTFCM N/A
  • Earning Date
  • GALT 11-13-2024
  • WTFCM N/A
  • Dividend Yield
  • GALT N/A
  • WTFCM N/A
  • EPS Growth
  • GALT N/A
  • WTFCM N/A
  • EPS
  • GALT N/A
  • WTFCM N/A
  • Revenue
  • GALT N/A
  • WTFCM N/A
  • Revenue This Year
  • GALT N/A
  • WTFCM N/A
  • Revenue Next Year
  • GALT N/A
  • WTFCM N/A
  • P/E Ratio
  • GALT N/A
  • WTFCM N/A
  • Revenue Growth
  • GALT N/A
  • WTFCM N/A
  • 52 Week Low
  • GALT $0.73
  • WTFCM N/A
  • 52 Week High
  • GALT $4.27
  • WTFCM N/A
  • Technical
  • Relative Strength Index (RSI)
  • GALT 20.80
  • WTFCM 60.51
  • Support Level
  • GALT $1.80
  • WTFCM $24.89
  • Resistance Level
  • GALT $2.36
  • WTFCM $25.27
  • Average True Range (ATR)
  • GALT 0.27
  • WTFCM 0.08
  • MACD
  • GALT -0.08
  • WTFCM -0.00
  • Stochastic Oscillator
  • GALT 15.07
  • WTFCM 100.00

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

About WTFCM Wintrust Financial Corporation Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series D

Wintrust Financial Corp is a financial holding company operating in the Chicago metropolitan area and southern Wisconsin through its wholly-owned banking subsidiaries. Wintrust conducts its business through three segments: community banking, specialty finance, and wealth management. Among other services, the company provides community-oriented, personal, and commercial banking, as well as the origination and purchase of residential mortgages for sale into the secondary market. A majority of its banks are banks chartered by the state of Illinois with scores of locations. The company has historically grown through both de novo organization and acquisitions. A majority of its loan portfolio is commercial, mostly in real estate. A majority of Wintrust's net revenue is net interest income.

Share on Social Networks: